Emmalyn Chen - Concepedia

Author

Emmalyn Chen

University of California, San Francisco ORCID

Also Known As

Emmalyn Chen

Publications

179

Citations

H-Index

Concepts

All Affiliations

University of California, San Francisco Case Western Reserve University Stanford University Duke Cancer Institute University of Maryland, Baltimore

About

Emmalyn Chen is an author at University of California, San Francisco specializing in medicine, oncology, and computational pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	45
2	Health Sciences	2	2	30
3	Artificial Intelligence	2	2	28
4	Engineering	1	1	15
5	Pathology	1	1	17

Emmalyn Chen

Publications

161

Citations

H-Index

Page 1

	Year	Citations
Cell-free DNA concentration and fragment size as a biomarker for prostate cancer Emmalyn Chen, Clinton L. Cario, Lancelote Leong, Scientific Reports	2021	75
A machine learning approach to optimizing cell-free DNA sequencing panels: with an application to prostate cancer Clinton L. Cario, Emmalyn Chen, Lancelote Leong, BMC Cancer	2020	20
Leveraging sequences missing from the human genome to diagnose cancer Ilias Georgakopoulos‐Soares, Ofer Yizhar Barnea, Ioannis Mouratidis, GeneticsPathologyGenomicsTumor BiologyCancer Detection	2021	17
An AI-derived digital pathology-based biomarker to predict the benefit of androgen deprivation therapy in localized prostate cancer with validation in NRG/RTOG 9408. Daniel E. Spratt, Yilun Sun, Douwe Van der Wal, Journal of Clinical Oncology Artificial IntelligenceEngineeringNrg/rtog 9408Computational MedicineBiomarker (Medicine)	2022	15
Development and validation of an AI-derived digital pathology-based biomarker to predict benefit of long-term androgen deprivation therapy with radiotherapy in men with localized high-risk prostate cancer across multiple phase III NRG/RTOG trials. Andrew J. Armstrong, Vinnie YT Liu, Ramprasaath R. Selvaraju, Journal of Clinical Oncology Artificial IntelligenceBiomarker (Medicine)Prognostic BiomarkersUrologyCancer Epidemiology	2023	13
Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion Sequencing Emmalyn Chen, Clinton L. Cario, Lancelote Leong, JCO Precision Oncology	2021	11
External validation of a digital pathology-based multimodal artificial intelligence-derived prognostic model in patients with advanced prostate cancer starting long-term androgen deprivation therapy: a post-hoc ancillary biomarker study of four phase 3 randomised controlled trials of the STAMPEDE platform protocol Charles Parker, Larissa Mendes, Vinnie Y.T. Liu, The Lancet Digital Health	2025	10

Page 1